Publication:


abstract

Research on the importance of serum uric acid (SUA) as a contributing metabolic factor to cardiovascular diseases has conducted to conflicting results, with most studies assuming a Cross-sectional design. The aim of this study was to evaluate the association of SUA and metabolic syndrome (MetS) and its features. A representative sample of 2,485 individuals aged ≥18 years was randomly selected from the non-institutionalized resident population of Porto, Portugal. A total of 1,054 eligible subjects were included for the longitudinal analyses. Hyperuricemia was defined as SUA ≥70 mg/L in men and ≥60 mg/L in women. MetS was defined according the Joint Interim (2009) criteria. associations were estimated using Poison regression and binomial models. In the cross-sectional analysis, subjects with hyperuricemia had a 2.10-fold increased risk of MetS as compared with normouricemic subjects (PR = 2.10, 95% CI: 1.68-2.63). Among MetS features, high triglycerides presented the strongest association with hyperuricemia (PR = 2.32, 95% CI: 1.84-2.91). The MetS crude incidence rate was 4.5/100 person-year (95% CI: 3.9-5.2) in normal uricemic and 13.0/100 person-year (95% CI: 8.5-20.0) in hyperuricemic participants. Using a multivariate longitudinal approach, hyperuricemia was positively associated with MetS incidence rate ratios (IRR = 1.73, 95% CI: 1.08-2.76). One standard deviation increase of SUA concentration was associated with a 1.22-fold increase in MetS risk (IRR = 1.22, 95% CI: 1.05-1.42). Elevated SUA presented the strongest association with high-triglycerides concentration (IRR = 1.44, 95%: 1.22-1.71) and waist circumference (IRR = 1.25, 95%: 1.05-1.49). The independent positive association between SUA and MetS suggested by this longitudinal study supports that SUA might be a risk factor for MetS.

Related Articles
Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study.
Atherosclerosis. 2012
Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study.
Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, Chien KL, Hwang LC, Su TC, Tseng CH, et al. Atherosclerosis. 2012 Feb; 220(2):525-31. Epub 2011 Nov 19.
High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population.
Metabolism. 2012
High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population.
Hara S, Tsuji H, Ohmoto Y, Amakawa K, Hsieh SD, Arase Y, Nakajima H. Metabolism. 2012 Feb; 61(2):281-8. Epub 2011 Aug 23.
The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects.
Acta Diabetol. 2011
The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects.
Meshkani R, Zargari M, Larijani B. Acta Diabetol. 2011 Mar; 48(1):79-88. Epub 2010 Nov 3.
Review Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
Metabolism. 2006
Review Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Metabolism. 2006 Oct; 55(10):1293-301.
Review Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?
Am J Med. 2005
Review Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?
Baker JF, Krishnan E, Chen L, Schumacher HR. Am J Med. 2005 Aug; 118(8):816-26.